Zobrazeno 1 - 10
of 708
pro vyhledávání: '"Cardiovascular risk assessment"'
Autor:
Ede Kékes
Publikováno v:
Cardiologia Hungarica, Vol 54, Iss 4, Pp 309-321 (2024)
Chronic kidney disease (CKD) and heart diseases (cardiovascular disease, atherosclerotic heart disease, heart failure) and metabolic diseases (metabolic syndrome [MetS], type 2 diabetes [T2DM], hyperuricemia) often occur together. The common, initiat
Externí odkaz:
https://doaj.org/article/ce14dee63e7c4986975d17ee7e0e2c14
Autor:
Katarzyna Nabrdalik, Krzysztof Irlik, Yanda Meng, Hanna Kwiendacz, Julia Piaśnik, Mirela Hendel, Paweł Ignacy, Justyna Kulpa, Kamil Kegler, Mikołaj Herba, Sylwia Boczek, Effendy Bin Hashim, Zhuangzhi Gao, Janusz Gumprecht, Yalin Zheng, Gregory Y. H. Lip, Uazman Alam
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Cardiac autonomic neuropathy (CAN) in diabetes mellitus (DM) is independently associated with cardiovascular (CV) events and CV death. Diagnosis of this complication of DM is time-consuming and not routinely performed in the clini
Externí odkaz:
https://doaj.org/article/caf7899cac6f43999cb6e01e9282ccaf
Autor:
Marie Dahl, Jesper Winkler Andersen, Jes Lindholt, Nikolaj Thure Krarup, Britt Borregaard, Nikolai Uberg, Annette Høgh
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Bilateral blood pressure (BP) measurement is important in cardiovascular prevention for identifying systolic interarm BP difference (IAD) and hypertension. We investigated sex-stratified IAD prevalence and its associations and coe
Externí odkaz:
https://doaj.org/article/399e3ffa635f47679b2152fce91ce751
Publikováno v:
Zhongguo quanke yixue, Vol 27, Iss 19, Pp 2336-2343 (2024)
Background Cardiovascular diseases seriously threaten the health of the elderly in our country and bring a huge economic burden to our country. Accurate screening of risk assessment tools for early cardiovascular diseases can specifically prevent and
Externí odkaz:
https://doaj.org/article/fc6e81cfc99c48f0afeaa1f7debd7383
Autor:
Tomer Gazit, Hanan Mann, Shiri Gaber, Pavel Adamenko, Granit Pariente, Liron Volsky, Amir Dolev, Helena Lyson, Eyal Zimlichman, Jay A. Pandit, Edo Paz
Publikováno v:
Frontiers in Digital Health, Vol 6 (2024)
BackgroundCurrent atherosclerotic cardiovascular disease (ASCVD) risk assessment tools like the Pooled Cohort Equations (PCEs) and PREVENT™ scores offer long-term predictions but may not effectively drive behavior change. Short-term risk prediction
Externí odkaz:
https://doaj.org/article/e84aa64774234526a98e31f9e1ead26f
Publikováno v:
BMC Primary Care, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background SCORE2 has been introduced as an updated risk assessment tool for calculating the 10-year risk of first-onset cardiovascular disease (CVD). However, it does not account for ethnicity or socioeconomic status, known to affect CVD ri
Externí odkaz:
https://doaj.org/article/c95b5a59520d47799cb956a526770e3c
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 6, Pp 17-22 (2024)
Background: Estimation of the risk of future atherosclerotic cardiovascular (CV) events is an important step in the primary prevention of CV events. However, the relative accuracy of the various currently available CV risk scores is not validated in
Externí odkaz:
https://doaj.org/article/2282e6171e5b4640983dc8b94691235c
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Subclinical cardiovascular disease (Sub-CVD) is an early stage of cardiovascular disease and is often asymptomatic. Risk factors, including hypertension, diabetes, obesity, and lifestyle, significantly affect Sub-CVD. Progress in imaging technology h
Externí odkaz:
https://doaj.org/article/d1c8037524824a849af9b115999ac47c
Autor:
Vikulova, Diana N. a, b, Lee, May Kuen c, Humphries, Karin H. c, Pinheiro-Muller, Danielle a, Dawes, Martin d, Pimstone, Simon N. b, e, Brunham, Liam R. a, b, f, ∗
Publikováno v:
In JACC: Advances January 2025 4(1)
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Background In accordance with the EULAR recommendations, the Danish Hospital for Rheumatic Diseases have systematically invited patients with rheumatoid arthritis (RA) to cardiovascular (CV) risk assessment since 2011. Patients with high ris
Externí odkaz:
https://doaj.org/article/e3b3fbded571414a8bd6ad9a02a98843